Insulet has considerably underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.
/Doctor%20scientist%20looking%20at%20test%20tube%20solution%20by%20MIND%20AND%20I%20via%20Adobe%20Stock.jpeg)
Despite its disappointing performance relative to the broader market over the past year, Stryker continues to enjoy strong backing from Wall Street.
/BD%20Canada's%20head%20office%20building%20in%20Mississauga%2C%20On%2C%20Canada_%20%20By%20JHVEPhoto.jpeg)
Becton, Dickinson and Company has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
/Zimmer%20Biomet%20headquarters_By%20jetcityimage.jpeg)
Zimmer Biomet has underperformed the broader market over the past year, and analysts are cautious about the stock’s prospects.
/GE%20HealthCare%20Technologies%20Inc_%20on%20screen%20in%20front%20of%20business%20logo%20By%20Timon.jpeg)
GE HealthCare has lagged the broader market despite strong earnings, while analysts remain moderately optimistic about its future prospects.
/Medtronic%20Plc%20HQ-by%20JHVEPhoto%20via%20iStock.jpg)
Medtronic has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.
/Baxter%20sign%20on%20the%20building%20in%20Mississauga%2C%20Ontario_%20Baxter%20International%20Inc_%20By%20JHVEPhoto.jpeg)
Baxter International has significantly underperformed the broader market over the past year, although analysts remain neutral amid improving fundamentals and recovery prospects.
/Boston%20Scientific%20sign%20at%20manufacturer%20of%20medical%20devices%20Silicon%20Valley%20office%20By%20MichaelVi.jpeg)
Boston Scientific underperformed the broader market, though analysts remain optimistic, citing strong earnings execution, innovation, and meaningful upside from current levels.
/Intuitive%20Surgical%20Inc%20location%20sign-by%20Sundry%20Photography%20via%20iStock.jpg)
J&J’s Ottava clearance knocked Intuitive's shares lower, but recurring revenue and surgeon switching costs suggest the market overreacted.
It’s time to start looking at the other 10 sectors of the S&P 500 to see what looks most likely to pick up the slack if and when the artificial intelligence (AI) trade finally loses steam.